Showing 1 - 4 results of 4 for search 'Kathryn T. Whelan' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Kathryn T. Whelan
Showing 1 - 4 results of 4 for search 'Kathryn T. Whelan', query time: 0.02s Refine Results
  1. 1
    Rapidly enlarging nontender lesion on a child’s face

    Rapidly enlarging nontender lesion on a child’s face by Fiona M. Landells, BSc, Michelle E. Pratt, MD, DABD, Sarah E. Finch, MD, Kathryn P. Whelan, MD

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.

    Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A. by Kathryn T. Whelan, Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Adrian V. S. Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article
  3. 3
    Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

    Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials. by Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Natalie E R Beveridge, Kathryn T Whelan, Adrian V S Hill, Helen McShane

    Published 2007-10-01
    Get full text
    Article
  4. 4
    Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials.

    Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials. by Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Natalie E. R. Beveridge, Kathryn T. Whelan, Adrian V. S. Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs